Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BEAM stock hub

Beam Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BEAMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BEAM

In the news

Latest news · BEAM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-5.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-17.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BEAM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000789073
Company name	Beam Therapeutics Inc.
Country	United States
Country code	US
Cusip	07373V105
Employees	511
Employees Change	28%
Employees Change Percent	5.8
Enterprise value	$2.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-02-06
Isin	US07373V1052
Last refreshed	2026-05-10
Market cap	$3.2B
Market cap category	Mid-Cap
Price	$32.32
Price currency	USD
Rev Per Employee	320,960.86x
Sector	Healthcare
Sic	2080
Symbol	BEAM
Website	https://beamtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.05%
EV Sales Forward	42.84x
EV/Sales	13.76x
FCF yield	-11.93%
P/B ratio	2.76x
P/S ratio	19.61x
PS Forward	61.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-226.58%
EBITDA Margin	-212.94%
Gross margin	-146.9%
Gross Profit	$-240.9M
Net Income	$-66M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-40.23%
Profit Margin	-40.23%
Profit Per Employee	$-129,119
ROA	-15.76
Roa5y	-15.43
ROCE	-26.43
ROE	-5.77
Roe5y	-34.74
ROIC	-17.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	99.29%
Cagr3y	-1.33%
Cagr5y	-14.52%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	157.97x
Revenue Growth Q	324.87x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	28.83x
Revenue Growth5 Y	484.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.11
Assets	$1.5B
Cash	$1.2B
Current Assets	$1.3B
Current Liabilities	$74.6M
Debt	$250.8M
Debt Equity	$0.22
Equity	$1.2B
Liabilities	$316.4M
Long Term Assets	$213.8M
Long Term Liabilities	$241.8M
Net Cash	$960.8M
Net Cash By Market Cap	$29.87
Net Cash Growth	-9.51%
Net Debt Equity	$-0.83
Tangible Book Value	$1.2B
Tangible Book Value Per Share	$11.71
WACC	15.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	16.99
Net Working Capital	$-4.5M
Quick ratio	16.25
Working Capital	$1.2B
Working Capital Turnover	$0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.47%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	99.2%
200-day SMA	25.28
3Y total return	-3.92%
50-day SMA	27.41
50-day SMA vs 200-day SMA	50over200
5Y total return	-54.36%
All Time High	138.5
All Time High Change	-76.67%
All Time High Date	2021-07-02
All Time Low	13
All Time Low Change	148.62%
All Time Low Date	2020-03-16
ATR	2.05
Beta	2.26
Beta1y	2.17
Beta2y	2.25
Ch YTD	16.6
High	32.47
High52	36.44
High52 Date	2026-01-12
High52ch	-11.31%
Low	30.91
Low52	15.35
Low52 Date	2025-05-30
Low52ch	110.55%
Ma50ch	17.92%
Premarket Change Percent	1.59
Premarket Price	$31.97
Premarket Volume	2,746
Price vs 200-day SMA	27.85%
RSI	59.9
RSI Monthly	55.97
RSI Weekly	59.58
Sharpe ratio	1.25x
Sortino ratio	2.34
Total Return	-22.47%
Tr YTD	16.6
Tr1m	31.97%
Tr1w	5.28%
Tr3m	21.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	4
Analyst Price Target Top	$63.5
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.98
Earnings Revenue Estimate	13,940,992x
Earnings Revenue Estimate Growth	86.63x
Operating Income	$-371.6M
Operating margin	-226.6
Price target	$48.4
Price Target Change	$49.75
Price Target Change Top	$96.47

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	88,045,322%
Float Percent	88.46%
Net Borrowing	93,886,000
Shares Insiders	1.43%
Shares Institutions	95.58%
Shares Out	99,536,654
Shares Qo Q	-1.59%
Shares Yo Y	22.47%
Short Float	25.24%
Short Ratio	10.36
Short Shares	22.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-470.5M
Average Volume	2,220,582.45x
Bv Per Share	11.71
CAPEX	$-14.1M
Ch1m	31.97
Ch1w	5.28
Ch1y	99.2
Ch3m	21.87
Ch3y	-3.92
Ch5y	-54.36
Ch6m	45.52
Change	2.7%
Change From Open	1.92
Close	31.47
Days Gap	0.76
Depreciation Amortization	22,371,000
Dollar Volume	92,215,003.8
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-371.6M
EBITDA	$-349.3M
EPS	$-0.64
F Score	3
FCF	$-383.8M
FCF EV Yield	-17.01x
FCF Per Share	$-3.86
Financing CF	101,278,000
Fiscal Year End	December
Founded	2,017
Investing CF	28,920,000
Ipr	90.12
Iprfo	34.67
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Ma150	27.08
Ma150ch	19.36%
Ma20	30.45
Ma20ch	6.15%
Net CF	-239,533,000
Next Earnings Date	2026-08-04
Open	31.71
Optionable	Yes
Position In Range	90.38
Post Close	32.32
Postmarket Change Percent	-0.34
Postmarket Price	$32.21
Ppne	199,395,000
Pre Close	31.47
Price Date	2026-05-08
Ptbv Ratio	2.76
Relative Volume	1.28x
Revenue	164,011,000x
SBC By Revenue	52.8x
Share Based Comp	86,606,000
Tr6m	45.52%
Us State	Massachusetts
Volume	2,853,187
Z Score	2.83

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BEAM pay a dividend?

Capital-return profile for this ticker.

Performance

BEAM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BEAM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+95.6%

Float: +88.5% of shares outstanding

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BEAM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.9

Neutral momentum band

Price vs 200-day MA

+27.8%

50/200-day relationship not available

Beta (5Y)

2.26

More volatile than the market

Sharpe ratio

1.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BEAM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BEAM stock rating?

Beam Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BEAM analysis?

The full report lives at /stocks/BEAM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BEAM?

The latest report frames BEAM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BEAM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.